Jie Wu to Carcinoma, Non-Small-Cell Lung
                            
                            
                                This is a "connection" page, showing publications Jie Wu has written about Carcinoma, Non-Small-Cell Lung.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.627
         
        
        
     
 
    
        
        - 
            Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutations. Ann Oncol. 2021 02; 32(2):261-268.
            
            
                Score: 0.627